Hisamitsu Pharmaceutical Co Stock Fundamentals

HPX Stock  EUR 25.20  0.20  0.80%   
Hisamitsu Pharmaceutical Co fundamentals help investors to digest information that contributes to Hisamitsu Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Hisamitsu Stock. The fundamental analysis module provides a way to measure Hisamitsu Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hisamitsu Pharmaceutical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Hisamitsu Pharmaceutical Co Company Profit Margin Analysis

Hisamitsu Pharmaceutical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Hisamitsu Pharmaceutical Profit Margin

    
  0.10 %  
Most of Hisamitsu Pharmaceutical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hisamitsu Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Hisamitsu Pharmaceutical Co has a Profit Margin of 0.1034%. This is 100.92% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all Germany stocks is 108.14% lower than that of the firm.

Hisamitsu Pharmaceutical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hisamitsu Pharmaceutical competition to find correlations between indicators driving Hisamitsu Pharmaceutical's intrinsic value. More Info.
Hisamitsu Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.42  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hisamitsu Pharmaceutical Co is roughly  2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Hisamitsu Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hisamitsu Pharmaceutical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hisamitsu Pharmaceutical could also be used in its relative valuation, which is a method of valuing Hisamitsu Pharmaceutical by comparing valuation metrics of similar companies.
Hisamitsu Pharmaceutical is rated # 5 in profit margin category among its peers.

Hisamitsu Fundamentals

About Hisamitsu Pharmaceutical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hisamitsu Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hisamitsu Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hisamitsu Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Hisamitsu Stock

Hisamitsu Pharmaceutical financial ratios help investors to determine whether Hisamitsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hisamitsu with respect to the benefits of owning Hisamitsu Pharmaceutical security.